ApoE-driven AD pathologies differ from pure amyloid pathologies [117, 118] and our prior work indicates apoE can regulate MMP9 disposition in the brain, and the apoE4 isoform in particular is associated with elevated MMP9 levels and activity [18]. This evidence concerns the gene MMP9 and Alzheimer disease.